Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Other Non-Current Assets (2019 - 2025)

Cresco Labs' Other Non-Current Assets history spans 7 years, with the latest figure at $14.1 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 5.94% year-over-year to $14.1 million; the TTM value through Dec 2025 reached $14.1 million, down 5.94%, while the annual FY2025 figure was $14.1 million, 5.94% down from the prior year.
  • Other Non-Current Assets reached $14.1 million in Q4 2025 per CRLBF's latest filing, down from $15.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $15.0 million in Q4 2024 to a low of $2.2 million in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $7.8 million, with a median of $5.1 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: tumbled 30.99% in 2021, then soared 194.44% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $2.6 million in 2021, then fell by 15.24% to $2.2 million in 2022, then soared by 134.72% to $5.1 million in 2023, then skyrocketed by 194.44% to $15.0 million in 2024, then decreased by 5.94% to $14.1 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Other Non-Current Assets are $14.1 million (Q4 2025), $15.0 million (Q4 2024), and $5.1 million (Q4 2023).